MedTrace Logo

Post-Market Study of the EPIK Knee System

NCT01464632 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2012-05-16

No results posted yet for this study

Summary

The purpose of this study is to determine the short-term (2 yr) and midterm (5 yr) cumulative revision rates of the EPIK™ Uni-compartmental Knee System.

Conditions

Interventions

DEVICE

EPIK™ uni-compartmental knee

This device is intended for partial replacement of the articulating surfaces of the knee when only one side of the joint is affected due to compartmental primary degenerative or post-traumatic degenerative disease, previous tibial condyle or plateau fractures, deformity, or revision of previous arthroplasty.

Sponsors & Collaborators

  • Encore Medical, L.P.

    lead INDUSTRY

Principal Investigators

  • Christina M Sheely, D.O. · Hill Country Sports Medicine

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2012-05-31
Completion
2012-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01464632 on ClinicalTrials.gov